Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade.

Overview of attention for article published in Clinical Cancer Research, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 2 news outlets

twitter: 16 X users

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 23 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Researchers Identify Biomarkers to Predict Patient Response to Immunotherapy Treatment for Melanoma

OncLive, 18 Nov 2022

In Partnership With: A team of researchers at Wake Forest School of Medicine, led by David R.

New Blood Biomarkers May Predict Response to Melanoma Immunotherapy

GEN, 18 Feb 2022

Scientists at the Wake Forest School of Medicine, led by David R. Soto-Panjota, PhD, associate professor of surgery and cancer…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.